TWO SIGMA SECURITIES, LLC
Broker-DealerPosition in ESPR — Esperion Therapeutics, Inc.
CIK 1450144
NEW YORK, NY
Position in ESPR
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$76,470
+$41,816 QoQ
Shares Held
27,909
+113.4% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2023
4 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ESPR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026TWO SIGMA SECURITIES, LLC holds $1,110,248 across 13 Drug Manufacturers - Specialty & Generic names. ESPR ranks #6 (6.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
510 | $302,419 | |
| 2 | ELAN |
Elanco Animal Health Inc
|
10,720 | $256,529 | |
| 3 | LQDA |
Liquidia Corp
|
5,496 | $207,419 | |
| 4 | CGC |
Canopy Growth Corp
|
99,372 | $94,304 | |
| 5 | AQST |
Aquestive Therapeutics, Inc.
|
18,770 | $77,895 | |
| 6 | ESPR |
Esperion Therapeutics, Inc.
This page
|
27,909 | $76,470 | |
| 7 | SBFM |
Sunshine Biopharma Inc.
|
23,482 | $24,421 | |
| 8 | APUS |
Apimeds Pharmaceuticals US, Inc.
|
10,550 | $18,873 |
All Filings in ESPR
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $76,470 | 27,909 | Shares | Sole | 2026-05-15 | |
| 2025-09-30 | $34,654 | 13,077 | Shares | Sole | 2025-11-14 | |
| 2023-09-30 | $35,944 | 36,678 | Shares | Sole | 2023-11-14 | |
| 2023-03-31 | $18,749 | 11,792 | Shares | Sole | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||